The GROWTH consortium, funded by the European Commission (2019-2023), is made up to train a new generation of researchers working on new pathological insights, biomarker diagnostics and personalized nutritional interventions for intestinal failure in neonates and preterm infants.
Academic and industry partners, covering various disciplines ranging from fundamental research to clinical paediatrics and analytical chemistry to organoid and gut-on-chip applications, have teamed up in the European Union.
GROWTH aims to set-up a new European platform that trains young scientists in the industry-led exploration of innovative routes to fully exploit the potential of early life nutrition to prevent inflammatory disease. GROWTH coordinates 8 individual research projects.
If you have any questions you can fill in the form or mail us directly: email@example.com.
The gastrointestinal (GI) tract and nervous system are constantly communicating with each other in a bidirectional relation which is influenced by the immune system, the hypothalamic-pituitary axis and gut microbiota. Understanding the molecular and biochemical mechanisms disturbing the complex network of communication is key to our understanding of the pathophysiology of the functional GI disorders. With the proposed webinars, they would like to share the current views and an outlook on the future of the rapidly advancing field of neurogastroenterology.
They have prepared an exciting programme including the role of genetic factors, diet, microbiota, inflammation, diagnosis, and biomarkers, as well as current and future therapeutic approaches. The course will be held by a distinguished Faculty with expertise in the fields of neurogastroenterology, functional gastrointestinal disorders and microbiota.
More information about this free webinar series can be found HERE.
Wed, 21 April